°ÅÀÖÊÓƵ

ListenÌýto this episodeÌýonÌý,Ìý,Ìý, or theÌý.

Prostate-specific membrane antigen, or PSMA, is a protein expressed on the surface of prostate cancer cells that has become an important target for both diagnosing and treating the disease. In this episode of CancerCast, Dr. Manish Shah speaks with prostate cancer expert Dr. Scott Tagawa about how this PSMA protein helps identify whether prostate cancer is confined to the prostate or has spread, and the ways it can be used to guide treatment decisions. They discuss how PSMA-based prostate cancer treatments work in the body and why these therapies have become one of the most significant recent advances in modern medicine for prostate cancer.

Guest:ÌýScott Tagawa, MD, MS, Director of the Genitourinary Oncology Program and Medical Director of the Genitourinary Oncology Research Program at °ÅÀÖÊÓƵ/NewYork-Presbyterian Hospital.

Host:ÌýManish Shah, MD, Chief of Solid Tumor Service and Director of Gastrointestinal Oncology at °ÅÀÖÊÓƵ and NewYork-Presbyterian Hospital.

Conversations About New Developments in Cancer Care, ResearchÌýandÌýMedicine

New scientific developments are transforming the future of cancer treatment and care. Hosted by world-renowned medical oncologist Dr. Manish Shah,ÌýCancerCastÌýis your window into research breakthroughs, innovative therapies, and honest accounts of living with and beyond cancer.

Listen below or subscribe to the podcast onÌý,Ìý, andÌý. Questions orÌýsuggestions?ÌýEmailÌýus atÌýcancercast@med.cornell.edu.